Flash Glucose Monitoring Market Driven by Tech Integration and Innovation

The global flash glucose monitoring (FGM) market is witnessing substantial growth, driven by the increasing prevalence of diabetes and the rising demand for innovative glucose monitoring solutions. In 2021, the market size was valued at USD 12,905 million, and it is projected to reach USD 24,765 million by 2030, growing at a compound annual growth rate (CAGR) of 7.6%. This report delves into the various dynamics shaping the FGM market, including market drivers, restraints, and opportunities.

REQUEST A $1000 DISCOUNT ON CREDIT CARD PURCHASE: https://www.acumenresearchandconsulting.com/inquiry-before-buying/866

Market Dynamics

Market Drivers

1. Growing Cases of Diabetes Globally The escalating number of diabetes patients worldwide is a primary driver of the FGM market. According to the International Diabetes Federation, approximately 537 million adults (20-79 years) were living with diabetes in 2021, and this number is expected to rise to 643 million by 2030 and 783 million by 2045. This surge in diabetes cases is propelling the demand for effective glucose monitoring systems like FGM, which offer a convenient and less invasive method of monitoring blood glucose levels.

2. Increasing Awareness Regarding Glucose Monitoring Devices There has been a significant increase in awareness about the importance of glucose monitoring among diabetic patients and healthcare providers. Campaigns and educational programs led by healthcare organizations and governments are playing a crucial role in disseminating information about the benefits of continuous glucose monitoring (CGM) systems. As awareness grows, more patients are adopting FGM devices to manage their diabetes effectively.

3. Increasing Demand for Point of Care Testing Point of care testing (POCT) allows for immediate diagnosis and treatment decisions at the location of patient care. The convenience and rapid results provided by POCT are driving its demand, especially in managing chronic conditions like diabetes. FGM systems, which enable real-time glucose monitoring without the need for frequent finger pricks, align well with the growing preference for POCT solutions.

4. Growing Healthcare Expenditure in Emerging Countries Emerging economies, particularly in Asia-Pacific and Latin America, are experiencing increased healthcare spending. Governments in these regions are investing heavily in healthcare infrastructure and services to improve access to quality care. This trend is fostering the adoption of advanced medical devices, including FGM systems, thereby boosting market growth.

Download Sample Report Copy of This Report from Here: https://www.acumenresearchandconsulting.com/request-sample/866

Market Restraints

1. Overburdened Information from FGM Sensors One of the challenges faced by users of FGM systems is the overwhelming amount of data generated by the sensors. While continuous monitoring provides comprehensive glucose readings, it can also lead to information overload for patients and healthcare providers. Managing and interpreting this data effectively requires proper training and tools, which can be a barrier for some users.

2. FGM Sensors Cause Skin Irritation Another notable restraint is the potential for skin irritation caused by FGM sensors. Prolonged use of these sensors can lead to allergic reactions or discomfort for some patients, which may deter them from using the devices consistently. Addressing this issue is crucial for improving patient compliance and satisfaction with FGM systems.

Market Opportunities

1. Technological Advancement in Healthcare Sector The healthcare sector is witnessing rapid technological advancements, including the development of more accurate, reliable, and user-friendly glucose monitoring devices. Innovations such as improved sensor technology, better connectivity features, and integration with mobile health applications are enhancing the functionality and appeal of FGM systems. These advancements are expected to create significant growth opportunities for market players.

2. Rising Patient Adoption Towards Non-Invasive Procedures There is a growing preference for non-invasive medical procedures among patients, driven by the desire for less pain, lower risk of complications, and quicker recovery times. FGM systems, which eliminate the need for frequent finger pricks, offer a non-invasive alternative for glucose monitoring. As more patients become aware of and comfortable with these non-invasive options, the adoption of FGM devices is likely to increase.

Flash Glucose Monitoring Market Segmentation

The market can be bifurcated on the basis of application, end-user, and region.

Flash Glucose Monitoring Market by Application
• Type 1-Diabetes
• Type 2-Diabetes

Flash Glucose Monitoring Market by End-User
• Hospital
• Clinics
• Academic & Research Institutes
• Others

By Region

1. North America North America holds a significant share of the global FGM market, driven by the high prevalence of diabetes, advanced healthcare infrastructure, and strong awareness about CGM systems. The presence of leading market players and ongoing technological advancements are further supporting market growth in this region.

2. Europe Europe is another major market for FGM systems, characterized by well-established healthcare systems and a high adoption rate of advanced medical devices. Increasing healthcare expenditure and supportive government initiatives are boosting market growth in this region.

3. Asia-Pacific The Asia-Pacific region is expected to witness the fastest growth in the FGM market, fueled by the rising prevalence of diabetes, improving healthcare infrastructure, and increasing healthcare spending. Countries like China and India are key contributors to the market growth in this region.

4. Latin America Latin America is also emerging as a promising market for FGM systems, driven by the growing awareness about diabetes management and the increasing adoption of advanced healthcare technologies. Government initiatives to improve healthcare access and quality are supporting market growth in this region.

5. Middle East and Africa The Middle East and Africa region is witnessing gradual growth in the FGM market, supported by rising healthcare investments and increasing awareness about diabetes management. However, challenges such as limited healthcare infrastructure and affordability issues may hinder market growth in some areas.

Flash Glucose Monitoring Market Players

Some of the global flash glucose monitoring companies profiled in the report includes Abbott laboratories, Animas, Roche, Dexcom, Glysens, Medtronic, Omnipod Senseonics, and Ypsomed.

Competitive Landscape
The global flash glucose monitoring market is characterized by intense competition among key players, including Abbott Laboratories, Medtronic plc, Dexcom, Inc., and others. These companies are focusing on product innovation, strategic partnerships, and mergers and acquisitions to strengthen their market position and expand their product offerings.

Abbott Laboratories Abbott Laboratories is a leading player in the FGM market, known for its FreeStyle Libre system. The company is continuously investing in research and development to enhance the performance and features of its glucose monitoring devices.

Medtronic plc Medtronic plc is another prominent player in the market, offering a range of CGM systems, including the Guardian Connect system. The company is focused on expanding its product portfolio and improving patient outcomes through innovative solutions.

Dexcom, Inc. Dexcom, Inc. is a major competitor in the FGM market, recognized for its G6 and G7 CGM systems. The company is committed to advancing CGM technology and providing accurate and reliable glucose monitoring solutions for diabetes patients.

Flash Glucose Monitoring Market Table of Content:

CHAPTER 1. Industry Overview of Flash Glucose Monitoring Market
CHAPTER 2. Research Approach
CHAPTER 3. Market Dynamics And Competition Analysis
CHAPTER 4. Flash Glucose Monitoring Market By Application
CHAPTER 5. Flash Glucose Monitoring Market By End-User
CHAPTER 6. North America Flash Glucose Monitoring Market By Country
CHAPTER 7. Europe Flash Glucose Monitoring Market By Country
CHAPTER 8. Asia Pacific Flash Glucose Monitoring Market By Country
CHAPTER 9. Latin America Flash Glucose Monitoring Market By Country
CHAPTER 10. Middle East & Africa Flash Glucose Monitoring Market By Country
CHAPTER 11. Player Analysis Of Flash Glucose Monitoring Market
CHAPTER 12. Company Profile

Conclusion
The global flash glucose monitoring market is poised for significant growth in the coming years, driven by the increasing prevalence of diabetes, rising awareness about glucose monitoring devices, and technological advancements in the healthcare sector. While challenges such as information overload and skin irritation from sensors exist, the market offers substantial opportunities for innovation and expansion. Key market players are actively investing in research and development to address these challenges and capitalize on the growing demand for FGM systems. As the market continues to evolve, FGM devices are expected to play a crucial role in improving diabetes management and enhancing patient outcomes.

Ask Query Here: Richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/866

Browse for more Related Reports
https://www.globenewswire.com/news-release/2022/08/23/2503421/0/en/Flash-Glucose-Monitoring-Market-Size-To-Grow-At-CAGR-7-6-And-Reach-Market-Value-of-USD-24-765-Million-by-2030-Exclusive-Report-By-Acumen-Research-and-Consulting.html

201, Vaidehi-Saaket, Baner - Pashan Link Rd, Pashan, Pune, Maharashtra 411021

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

This release was published on openPR.